TrialCancer medicine2026

Transcriptome Analysis Identifies a Myeloid-Like Signature in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy.

Shisen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.